SHANGHAI, Aug. 1, 2024
/PRNewswire/ -- Angel Yeast
(SH600298), a global leader in yeast manufacturing, is spearheading
an initiative that unites universities and enterprises to form an
innovative consortium dedicated to advancing synthetic biology
technology. This initiative also accelerates the construction of
the Xiaoting Synthetic Biology Industrial Park in Yichang,
Hubei Province. The goal is to
establish an integrated industry chain, starting with yeast
production and extending through fermentation of raw materials, bio-manufacturing, and
product application. By 2035, this initiative aims to develop a
50-billion-yuan (USD 6.89 billion) industry cluster.
In the era of rapid technology development, synthetic biology
has been coined "the third biological science revolution" It makes
each cell a "super factory" that can continuously produce specific
substances after targeted modification, to be widely used in the
manufacturing of food, medicine, biochemicals, new materials and
more. At present, yeast is one of the most applicable microbial
cell factory platforms with high editability and
controllability.
As a global leader in the field of yeast R&D and production,
Angel Yeast has been laying out the
industry roadmap for synthetic biology to accelerate its
development. With this in mind, the Xiaoting Synthetic Biology
Industrial Park was unveiled in 2023 and the consortium was founded
in May 2024.
"The consortium will focus on tackling the bottlenecks of core
technologies, advancing the development of
bio-based materials, pharmaceutical
intermediates, biomass sugar and more following
market-oriented operation strategies, while actively promoting to
develop the standards for synthetic biology and layout for
acquiring invention patents of the industry," said Zhang Yan, Dean of the Angel Yeast Research
Institute.
The yeast extract production of the project requires more than
100 kilograms of enzymes per day, supplied by Angel Yeast's enzyme preparation operations. The
first phase of the project is now in production to manufacture
vitamin K2, pyrroloquinoline quinone disodium salt,
phosphatidylserine and other products.
Building an intelligent, digital, and automated
factory
Angel Yeast's green production
base has been transformed to achieve high levels of automation,
intelligent and digital operation, while leading in production
capacity, while the green recycling and circular production model
is also contributing to sustainable development.
The intelligent factory is equipped with smart AGV lift trucks
to support the high-efficiency operation of production lines, and
coupled with 13 robots, four production lines have fully realized
automated manufacturing. In 2023, Angel
Yeast's factory in Yichang produced 40,000 tons of yeast
products reaching 1
billion yuan (USD 137.9
million). In the first half of 2024, it has achieved an
output value of 508 million yuan
(USD 70.05 million), a 20.8 percent
year-on-year increase.
PHA is a new biodegradable material to replace plastics. Hubei PHAngel Biotechnology,
a joint venture by Angel Yeast and
Beijing PhaBuilder, is building a PHA production line with
production capacity of 30,000 tons by two phases with total
investment of 1.05 billion yuan
(USD 144.79 million), which upon
completion will become the world's largest scale PHA production
line boasting the most varieties of PHA products.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/angel-yeast-brings-together-innovative-consortium-to-build-industrial-park-for-synthetic-biology-development-302211093.html
SOURCE Angel Yeast